Colgate-Palmolive (NYSE:CL) Shares Sold by S.E.E.D. Planning Group LLC

S.E.E.D. Planning Group LLC lessened its position in shares of Colgate-Palmolive (NYSE:CL) by 1.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,719 shares of the company’s stock after selling 120 shares during the quarter. S.E.E.D. Planning Group LLC’s holdings in Colgate-Palmolive were worth $793,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the third quarter valued at about $42,000. Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive in the 3rd quarter valued at approximately $53,000. Prospera Private Wealth LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter valued at $64,000. True Wealth Design LLC increased its position in Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after buying an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC raised its holdings in shares of Colgate-Palmolive by 93.4% in the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after acquiring an additional 368 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.37% of the stock is owned by corporate insiders.

Colgate-Palmolive Trading Up 0.7 %

NYSE CL opened at $87.73 on Wednesday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company’s 50 day moving average price is $92.36 and its 200 day moving average price is $97.92. The firm has a market capitalization of $71.68 billion, a price-to-earnings ratio of 25.14, a PEG ratio of 3.31 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. Colgate-Palmolive’s payout ratio is 57.31%.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of recent research reports. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price target for the stock from $105.00 to $101.00 in a report on Monday, October 28th. JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $103.63.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.